These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36799449)

  • 1. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
    Kundu D; Kennedy L; Zhou T; Ekser B; Meadows V; Sybenga A; Kyritsi K; Chen L; Ceci L; Wu N; Wu C; Glaser S; Carpino G; Onori P; Gaudio E; Alpini G; Francis H
    Hepatology; 2023 Jul; 78(1):243-257. PubMed ID: 36799449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
    Kennedy L; Meadows V; Sybenga A; Demieville J; Chen L; Hargrove L; Ekser B; Dar W; Ceci L; Kundu D; Kyritsi K; Pham L; Zhou T; Glaser S; Meng F; Alpini G; Francis H
    Hepatology; 2021 Jul; 74(1):164-182. PubMed ID: 33434322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
    Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
    Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
    Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling.
    Qian LL; Ji JJ; Jiang Y; Guo JQ; Wu Y; Yang Z; Ma GS; Yao YY
    FASEB J; 2022 May; 36(5):e22316. PubMed ID: 35429042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis.
    Lee S; Usman TO; Yamauchi J; Chhetri G; Wang X; Coudriet GM; Zhu C; Gao J; McConnell R; Krantz K; Rajasundaram D; Singh S; Piganelli J; Ostrowska A; Soto-Gutierrez A; Monga SP; Singhi AD; Muzumdar R; Tsung A; Dong HH
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
    Xu M; Zheng XM; Jiang F; Qiu WQ
    J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.
    Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
    Dig Dis Sci; 2016 Nov; 61(11):3190-3198. PubMed ID: 27572941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.
    Compagnoni C; Capelli R; Zelli V; Corrente A; Vecchiotti D; Flati I; Di Vito Nolfi M; Angelucci A; Alesse E; Zazzeroni F; Tessitore A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
    Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
    Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota.
    Shou DW; Quan Y; Cheng JM; Yang SQ; Chen JW; Li YQ; Huang C; Chen HT; Zhou YJ
    J Dig Dis; 2024 Jul; 25(7):453-462. PubMed ID: 39211938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.
    Ding J; Xu M; Du W; Fang ZQ; Xu H; Liu JJ; Song P; Xu C; Li ZW; Yue ZS; Ling YW; Duan JL; Tao KS; He F; Wang L
    Int J Biol Sci; 2023; 19(6):1941-1954. PubMed ID: 37063432
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway.
    Zhang Y; Li C; Li X; Wu C; Zhou H; Lu S; Liu X
    Mol Med Rep; 2020 Sep; 22(3):2174-2182. PubMed ID: 32705195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.